Idiopathic Choroidal Neovascularization: Intraocular Inflammatory Cytokines and the Effect of Intravitreal Ranibizumab Treatment. - Wikidata - wikimedia - TriplyDB

Idiopathic Choroidal Neovascularization: Intraocular Inflammatory Cytokines and the Effect of Intravitreal Ranibizumab Treatment.

Idiopathic Choroidal Neovascularization: Intraocular Inflammatory Cytokines and the Effect of Intravitreal Ranibizumab Treatment.

http://www.wikidata.org/entity/Q37202359

about

Retinal and choroidal angiogenesis: a review of new targets.Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis.

P2860

Q53098522-2B925199-988F-4A8C-9E26-F7E9662B05A4 Q54965847-220870DD-4F02-4FE2-AC46-9D9BE6DC0298

P2860

Idiopathic Choroidal Neovascularization: Intraocular Inflammatory Cytokines and the Effect of Intravitreal Ranibizumab Treatment.

http://www.wikidata.org/entity/Q37202359

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Idiopathic Choroidal Neovascul ...... vitreal Ranibizumab Treatment.

@en

Idiopathic Choroidal Neovascul ...... vitreal Ranibizumab Treatment.

@nl

type

label

Idiopathic Choroidal Neovascul ...... vitreal Ranibizumab Treatment.

@en

Idiopathic Choroidal Neovascul ...... vitreal Ranibizumab Treatment.

@nl

prefLabel

Idiopathic Choroidal Neovascul ...... vitreal Ranibizumab Treatment.

@en

Idiopathic Choroidal Neovascul ...... vitreal Ranibizumab Treatment.

@nl

P1433

Q37202359-6566E2F8-B6A3-479F-A520-600CD156B576

P1476

Q37202359-00A90C19-680E-4390-9994-7D012BE96F4D

P2093

Q37202359-1565E73D-5FDE-41FC-AC00-C9160E00C3DD

Q37202359-225A0098-A4CE-49E0-8BD8-C118A4A17788

Q37202359-23CEC92A-52F6-4401-9C2C-F175BBD5526B

Q37202359-3412091B-C637-4EC1-9566-DBBDFC47AD60

Q37202359-3A874EEC-BF67-4140-A92C-DACF064B63FA

Q37202359-41E57085-9643-4B6B-8EE7-0B0BF29FB849

Q37202359-5EE3FF76-36FD-4D71-A6C9-EBC5C3CC0DFD

Q37202359-9EACCD7A-8E3C-4951-91F4-6E1004BC2CDC

Q37202359-B3D41935-ABA2-4784-B4DD-F6585CF732A7

Q37202359-BD91E9C8-E35E-4B5D-86CE-B17D6B713893

P2860

Q37202359-04FC6F45-903D-4D41-B28C-8570EFE103BA

Q37202359-06DF698F-7D1D-49AD-9DD2-2AE36FCB4603

Q37202359-08767779-DC3F-4856-939C-74B305A11FB1

Q37202359-15C81BCD-0F99-4769-8B85-70750A0A4ECE

Q37202359-1B380986-488E-4C05-ADC1-0D8E057A7577

Q37202359-1BD06D32-2CAA-4782-94CA-1EBC2D786618

Q37202359-1C70B173-FD06-466B-A49C-09BE75F6EF70

Q37202359-1F5624DD-41A5-41C0-88F0-033ECFC58B58

Q37202359-26BDCFA9-4270-44FA-AE8A-B50D557D3ED4

Q37202359-270F7BAD-5890-466B-9ADB-BAF21623FF47

P2888

Q37202359-721A836D-39C9-4A15-A0F1-909DD8EEF0D3

P304

Q37202359-4C392B54-5CC5-422D-ACEB-8AD1A589EF9B

P31

Q37202359-6301FDEC-DEAA-42F1-96CC-8AE8D1F9D70D

P356

Q37202359-E5691644-5A62-4EAB-915A-8F331AC0A777

P407

Q37202359-034D024F-7C2D-4F31-A348-44A4A6AF364A

P478

Q37202359-0A22C153-E7BC-492C-AD92-050200E3133F

P577

Q37202359-EE3C67AC-7DA6-4A57-BDA9-ED9CBF0B1BB5

P698

Q37202359-E18B9636-DA5C-4839-B824-38354DDED922

P921

Q37202359-CDFFFB84-17B8-4FFE-A9BD-656C4F0E32F2

Q37202359-F12F4538-0094-40FB-A0CE-FFD96B79D706

P932

Q37202359-CB5E2757-CB06-4708-A5E7-AEBCFE486EB9

P356

P1433

Scientific Reports

P1476

Idiopathic Choroidal Neovascul ...... vitreal Ranibizumab Treatment.

@en

P2093

Fang Wu

http://www.w3.org/2001/XMLSchema#string

Houfa Yin

http://www.w3.org/2001/XMLSchema#string

Jian Ma

http://www.w3.org/2001/XMLSchema#string

Jinfu Yin

http://www.w3.org/2001/XMLSchema#string

Lei Feng

http://www.w3.org/2001/XMLSchema#string

Min Chen

http://www.w3.org/2001/XMLSchema#string

Panpan Ye

http://www.w3.org/2001/XMLSchema#string

Shenchao Guo

http://www.w3.org/2001/XMLSchema#string

Xiaoyun Fang

http://www.w3.org/2001/XMLSchema#string

Yabo Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Beyond VEGF: inhibition of the fibroblast growth factor pathway and antiangiogenesis

Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization

Age-related macular degeneration (AMD): pathogenesis and therapy.

Macrophages inhibit neovascularization in a murine model of age-related macular degeneration

High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.

Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.

Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development.

Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy.

LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study.

Cathepsin B: a potential prognostic marker for inflammatory breast cancer

P2888

P304

31880

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP31880

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27558944

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization

P932

4997256

http://www.w3.org/2001/XMLSchema#string